Hypoxia-responsive PPARGC1A/BAMBI/ACSL5 axis promotes progression and resistance to lenvatinib in hepatocellular carcinoma

Q Zhang, L Xiong, T Wei, Q Liu, L Yan, J Chen, L Dai… - Oncogene, 2023 - nature.com
Emerging evidence has indicated that peroxisome proliferator-activated receptor-gamma
coactivator-1α (PPARGC1A) is involved in hepatocellular carcinoma (HCC). However, its …
被引用次数：30 相关文章

Hypoxia-responsive PPARGC1A/BAMBI/ACSL5 axis promotes progression and resistance to lenvatinib in hepatocellular carcinoma

Q Zhang, L Xiong, T Wei, Q Liu, L Yan, J Chen… - …, 2023 - pubmed.ncbi.nlm.nih.gov
Emerging evidence has indicated that peroxisome proliferator-activated receptor-gamma
coactivator-1α (PPARGC1A) is involved in hepatocellular carcinoma (HCC). However, its …

Hypoxia-responsive PPARGC1A/BAMBI/ACSL5 axis promotes progression and resistance to lenvatinib in hepatocellular carcinoma.

Q Zhang, L Xiong, T Wei, Q Liu, L Yan, J Chen, L Dai… - Oncogene, 2023 - europepmc.org
Emerging evidence has indicated that peroxisome proliferator-activated receptor-gamma
coactivator-1α (PPARGC1A) is involved in hepatocellular carcinoma (HCC). However, its …